Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M6GC
|
||||
Former ID |
DIB007271
|
||||
Drug Name |
TRU-015
|
||||
Synonyms |
CytoxB20G; XXX_CytoxB20G; CD20 antagonist, Trubion; PF-5212374
|
||||
Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Phase 2 | [522257] | ||
Company |
Trubion Pharmaceuticals Inc; Trubion
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD20 | Target Info | Antagonist | [544418] | |
KEGG Pathway | Hematopoietic cell lineage | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.